Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
Curr Opin Nephrol Hypertens
    May 2018
  1. GUPTA N, Wish JB
    Erythropoietin mimetic peptides and erythropoietin fusion proteins for treating anemia of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 May 4. doi: 10.1097/MNH.0000000000000430.
    >> Share

  2. DEKKER MJE, Kooman JP
    Fluid status assessment in hemodialysis patients and the association with outcome: review of recent literature.
    Curr Opin Nephrol Hypertens. 2018;27:188-193.
    >> Share

    April 2018
  3. STRAUSSER SA, Nakano D, Souma T
    Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response.
    Curr Opin Nephrol Hypertens. 2018 Apr 26. doi: 10.1097/MNH.0000000000000424.
    >> Share

  4. MOE SM
    Rationale to reduce calcium intake in adult patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Apr 26. doi: 10.1097/MNH.0000000000000416.
    >> Share

  5. SCIALLA JJ
    Evidence basis for integrated management of mineral metabolism in patients with end-stage renal disease.
    Curr Opin Nephrol Hypertens. 2018 Apr 6. doi: 10.1097/MNH.0000000000000417.
    >> Share

    March 2018
  6. STELLER WAGNER MARTINS C, Jorgetti V, Moyses RMA
    Time to rethink the use of bone biopsy to prevent fractures in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Mar 31. doi: 10.1097/MNH.0000000000000418.
    >> Share

  7. ASHLEY J, Sood MM
    Novel oral anticoagulants in chronic kidney disease: ready for prime time?
    Curr Opin Nephrol Hypertens. 2018 Mar 22. doi: 10.1097/MNH.0000000000000410.
    >> Share

  8. CONNELLY K, Collister D, Tangri N
    Fracture risk and treatment in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2018 Mar 15. doi: 10.1097/MNH.0000000000000411.
    >> Share

    February 2018
  9. LI T, Xie Y, Al-Aly Z
    The association of proton pump inhibitors and chronic kidney disease: cause or confounding?
    Curr Opin Nephrol Hypertens. 2018 Feb 9. doi: 10.1097/MNH.0000000000000406.
    >> Share

    January 2018
  10. HAAS M
    Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts.
    Curr Opin Nephrol Hypertens. 2018 Jan 2. doi: 10.1097/MNH.0000000000000398.
    >> Share

    December 2017
  11. RAO M, Jaber BL, Balakrishnan VS
    Chronic kidney disease and acquired mitochondrial myopathy.
    Curr Opin Nephrol Hypertens. 2017 Dec 20. doi: 10.1097/MNH.0000000000000393.
    >> Share

    November 2017
  12. KRAUT JA, Madias NE
    Retarding progression of chronic kidney disease: use of modalities that counter acid retention.
    Curr Opin Nephrol Hypertens. 2017 Nov 14. doi: 10.1097/MNH.0000000000000386.
    >> Share

  13. SCHMIDT RJ
    Incorporating supportive care into the hemodialysis unit.
    Curr Opin Nephrol Hypertens. 2017;26:530-536.
    >> Share

    October 2017
  14. WALTHER CP, Chandra A, Navaneethan SD
    Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Oct 16. doi: 10.1097/MNH.0000000000000375.
    >> Share

    September 2017
  15. GOLPER TA
    Incremental dialysis: review of recent literature.
    Curr Opin Nephrol Hypertens. 2017 Sep 11. doi: 10.1097/MNH.0000000000000362.
    >> Share

  16. SY J, Johansen KL
    The impact of frailty on outcomes in dialysis.
    Curr Opin Nephrol Hypertens. 2017 Sep 9. doi: 10.1097/MNH.0000000000000364.
    >> Share

    August 2017
  17. GEORGIANOS PI, Agarwal R
    Blood pressure in hemodialysis: targets?
    Curr Opin Nephrol Hypertens. 2017 Aug 21. doi: 10.1097/MNH.0000000000000359.
    >> Share

  18. WONNACOTT A, Bowen T, Fraser DJ
    MicroRNAs as biomarkers in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Aug 12. doi: 10.1097/MNH.0000000000000356.
    >> Share

    March 2017
  19. HSU RK, Powe NR
    Recent trends in the prevalence of chronic kidney disease: not the same old song.
    Curr Opin Nephrol Hypertens. 2017 Mar 17. doi: 10.1097/MNH.0000000000000315.
    >> Share

  20. COLLISTER D, Rigatto C, Tangri N
    Anemia management in chronic kidney disease and dialysis: a narrative review.
    Curr Opin Nephrol Hypertens. 2017 Mar 16. doi: 10.1097/MNH.0000000000000317.
    >> Share

    February 2017
  21. DAVIS JL, Davison SN
    Hard choices, better outcomes: a review of shared decision-making and patient decision aids around dialysis initiation and conservative kidney management.
    Curr Opin Nephrol Hypertens. 2017 Feb 16. doi: 10.1097/MNH.0000000000000321.
    >> Share

  22. COWAN AC, Gharib EG, Weir MA
    Advances in the management of hyperkalemia in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Feb 15. doi: 10.1097/MNH.0000000000000320.
    >> Share

  23. MOORTHI RN, Avin KG
    Clinical relevance of sarcopenia in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Feb 13. doi: 10.1097/MNH.0000000000000318.
    >> Share

  24. RUZICKA M, Hiremath S
    Intensive blood pressure lowering in chronic kidney disease: the time has come.
    Curr Opin Nephrol Hypertens. 2017 Feb 13. doi: 10.1097/MNH.0000000000000316.
    >> Share

    November 2016
  25. GORDON CE, Nader C
    Evolving therapies for hepatitis C virus in chronic kidney disease: the beginning of a new era.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

    October 2016
  26. DHAYBI OA, Bakris G
    Mineralocorticoid antagonists in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

    September 2016
  27. MAVRAKANAS TA, Charytan DM
    Cardiovascular complications in chronic dialysis patients.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  28. CUNHA CB, D'Agata EM
    Implementing an antimicrobial stewardship program in out-patient dialysis units.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  29. TUMMALAPALLI L, Nadkarni GN, Coca SG
    Biomarkers for predicting outcomes in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

    August 2016
  30. LEE MB, Bargman JM
    Myths in peritoneal dialysis.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  31. KALRA PA, Bhandari S
    Safety of intravenous iron use in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  32. WOJCIECHOWSKI D, Vincenti F
    Current status of costimulatory blockade in renal transplantation.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  33. MATSUSHITA K, Ballew SH, Coresh J
    Cardiovascular risk prediction in people with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  34. AHMAD S, Bromberg JS
    Current status of the microbiome in renal transplantation.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  35. FRASER SD, Taal MW
    Multimorbidity in people with chronic kidney disease: implications for outcomes and treatment.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

    May 2016
  36. GINSBERG C, Ix JH
    Nicotinamide and phosphate homeostasis in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  37. LYTVYN Y, Bjornstad P, Pun N, Cherney DZ, et al
    New and old agents in the management of diabetic nephropathy.
    Curr Opin Nephrol Hypertens. 2016;25:232-9.
    >> Share

    November 2015
  38. TOWNSEND RR, Reese PP, Lim MA
    Should living kidney donors with hypertension be considered for organ donation?
    Curr Opin Nephrol Hypertens. 2015;24:594-601.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016